Organizational Strategy for Substance Abuse Care Improvement
(LOCI-SL Trial)
Trial Summary
What is the purpose of this trial?
This project will test an implementation strategy that seeks to align system, organization, and clinic leadership strategies to implement and sustain the Lyssn artificial intelligence (AI) quality assurance platform to support implementation of Motivational Interviewing (MI) and evidence-based practice (EBP) for substance use disorders. The Leadership and Organizational Change for Implementation - System Level (LOCI-SL) strategy seeks to engage policymakers and funders at the system level to improve implementation leadership, climate, provider attitudes and behaviors at the provider organization level to enhance implementation climate for EBP. LOCI-SL will be tested in a statewide addiction service system through clinics in community based behavioral health organizations.
Do I need to stop my current medications for this trial?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Leadership and Organizational Change for Implementation (LOCI) for substance abuse care improvement?
Research shows that the LOCI intervention, which focuses on improving leadership and organizational strategies, has been effective in implementing evidence-based practices in various settings, including mental health clinics and correctional facilities. These studies suggest that improving leadership and organizational processes can enhance the implementation of treatments, potentially benefiting substance abuse care.12345
How is the LOCI-SL treatment different from other treatments for substance abuse?
The LOCI-SL treatment is unique because it focuses on improving leadership and organizational strategies to implement evidence-based practices effectively, rather than directly targeting the substance abuse itself. This approach aims to enhance the overall functioning and capacity of treatment organizations, making it different from traditional treatments that focus solely on the individual receiving care.12567
Eligibility Criteria
This trial is for staff at provider or payer advocacy organizations, executives and managers at substance use disorder/mental health treatment agencies, clinic supervisors, counselors providing such treatments in Oregon and Indiana. It includes stakeholders from relevant state authorities and managed care organizations.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Preparation
Engagement with state policy and funding stakeholders to align strategies for EBP implementation
Implementation
Implementation of the Lyssn AI platform and Motivational Interviewing using the LOCI-SL strategy
Sustainment
Ongoing support and evaluation of EBP implementation and sustainment
Follow-up
Participants are monitored for changes in implementation leadership and climate
Treatment Details
Interventions
- Leadership and Organizational Change for Implementation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor
Pacific Institute for Research and Evaluation
Collaborator
Oregon Social Learning Center
Collaborator
Indiana University
Collaborator
Chestnut Health Systems
Collaborator
University of Central Florida
Collaborator